American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D003913:Dextroamphetamine / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010389:Pemoline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine